ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway

Zhang, Yue; Wang, Dongwei; Wu, Kaili; Shao, Xiaoqi; Diao, Hongtao; Wang, Zhiying; Sun, Mengxian; Huang, Xueying; Li, Yun; Tang, Xinyuan; Yan, Meiling; Guo, Jiao*广东药学院
Evidence-based Complementary and Alternative Medicine2022-4-19DOI: 10.1155/2022/5642307
2被引15阅读
引用收藏
分享

摘要

Background. Fu fang Zhen Zhu Tiao Zhi (FTZ) is a patented preparation of Chinese herbal medicine that has been used as a natural medicine to treat several chronic diseases including cardiovascular disease. However, its effects on cardiac fibrosis remain unclear. Therefore, this study was designed to investigate the effects and potential mechanisms of FTZ in treating cardiac fibrosis. Methods. FTZ was administered to mice by oral gavage daily at a dosage of 1.2 g/kg or 2.4 g/kg of body weight for 7 weeks after a transverse aorta constriction (TAC) surgery. Doppler echocardiography, hematoxylin and eosin staining, and Masson's trichrome staining were used to assess the effect of FTZ on the cardiac structure and function of mice that had undergone TAC. EdU and wound-healing assays were performed to measure the proliferative and migratory abilities of cardiac fibroblasts. Western blotting and qRT-PCR were used to determine the expression of TGF beta 1, Col1A2, Col3, and alpha-SMA proteins and mRNA levels. Results. FTZ treatment reduced collagen synthesis, attenuated cardiac fibrosis, and improved cardiac function in mice subjected to TAC. Moreover, FTZ treatment prevented the proliferation and migration of cardiac fibroblasts and reduced Ang-II-induced collagen synthesis. Furthermore, FTZ downregulated the expression of TGF beta 1, p-smad2, and p-smad3 and inhibited the TGF beta 1-Smad2/3 pathway in the setting of cardiac fibrosis. Conclusion. FTZ alleviated the proliferation and migration of cardiac fibroblasts and suppressed collagen synthesis via the TGF beta 1-Smad2/3 pathway during the progression of cardiac fibrosis. These findings indicated the therapeutic potential of FTZ in treating cardiac fibrosis.

学科与关键词

关键词
FIBROBLASTSACTIVATIONDISEASE
相关
加载中…
  • FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway
    Zhang, Yue; Sun, Mengxian; Wang, Dongwei; Hu, Yaju; Wang, Ruonan; Diao, Hongtao; Shao, Xiaoqi; Li, Yun; Li, Xu; Leng, Mingyang; Wang, Lexun; Yan, Meiling; Rong, Xianglu; Guo, Jiao*Biomedicine and Pharmacotherapy, 2022, 148: 112696.被引 5
  • Taohong siwu decoction attenuates myocardial fibrosis by inhibiting fibrosis proliferation and collagen deposition via TGFBR1 signaling pathway
    Tan, Zhangbin; Jiang, Xiaoli; Zhou, Wenyi; Deng, Bo; Cai, Min; Deng, Suihui; Xu, Youcai; Ding, Wenjun; Chen, Guanghong; Chen, Ruixue; Zhang, Shuangwei; Zhou, Yingchun*; Liu, Bin*; Zhang, Jingzhi*Journal of Ethnopharmacology, 2021, 270: 113838.被引 19
  • Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis
    Shao, Xiaoqi; Huang, Bingying; Tan, Huiling; Wang, Ruonan; Huang, Xueying; Diao, Hongtao; Cheng, Jiawen; Sun, Mengxian; Wang, Dongwei; Wu, Kaili; Yan, Meiling; Rong, Xianglu; Zhang, Yue; Guo, JiaoEvidence-based Complementary and Alternative Medicine, 2022, 2022: 4752360.
查看全部 →

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-04-19
卷期
第 2022 卷
页码
5642307
DOI
10.1155/2022/5642307
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Key Project of National Natural Science Foundation of China [81830113]; National Key RD Plan [2018YFC1704200]; Major Basic and Applied Basic Research Projects of the Guangdong Province of China [2019B030302005]

作者

  • Z

    Zhang, Yue (第一作者)

    guangdong pharmaceut univ

  • W

    Wang, Dongwei

    guangdong pharmaceut univ

查看全部 12 位作者收起作者
  • W

    Wu, Kaili

    guangdong pharmaceut univ

  • S

    Shao, Xiaoqi

    guangdong pharmaceut univ

  • D

    Diao, Hongtao

    guangdong pharmaceut univ

  • W

    Wang, Zhiying

    guangdong pharmaceut univ

  • S

    Sun, Mengxian

    guangdong pharmaceut univ

  • H

    Huang, Xueying

    guangdong pharmaceut univ

  • L

    Li, Yun

    guangdong pharmaceut univ

  • T

    Tang, Xinyuan

    guangdong pharmaceut univ

  • Y

    Yan, Meiling

    guangdong pharmaceut univ

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417